Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MIRA

Mira Pharmaceuticals Inc

May 06 • 04:00PM ET

1.00

-0.02 -1.96 %

Healthcare • Drug Manufacturers - General • USA • Nano • NASD

Peers: CRON TLRY TVRD CGC ACB IIPR VFF DFTX

| Held by: VXF VTI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.52	Insider Own	16.58%	Shs Outstand	41.94M	Perf Week	-1.96%
Market Cap	42.02M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	35.05M	Perf Month	-2.91%
Enterprise Value	30.99M	PEG	-	EPS next Q	-	Inst Own	5.30%	Short Float	1.08%	Perf Quarter	-17.36%
Income	-32.00M	P/S	-	EPS this Y	-	Inst Trans	6.18%	Short Ratio	2.47	Perf Half Y	-41.18%
Sales	0.00M	P/B	4.04	EPS next Y	-	ROA	-456.59%	Short Interest	0.38M	Perf YTD	-33.77%
Book/sh	0.25	P/C	3.81	EPS next 5Y	-	ROE	-508.28%	52W High	2.45 -59.18%	Perf Year	-16.67%
Cash/sh	0.26	P/FCF	-	EPS past 3/5Y	-41.42% -211.56%	ROIC	-307.94%	52W Low	0.90 11.11%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.04% 4.79%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-213.66%	Oper. Margin	-	ATR (14)	0.06	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	15.75	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	42.19	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	15.75	EPS Q/Q	2.73%	SMA20	-4.20%	Beta	1.50	Target Price	8.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-9.10%	Rel Volume	0.67	Prev Close	1.02
Employees	2	LT Debt/Eq	0.00	Earnings	Dec 03	SMA200	-25.78%	Avg Volume	153.11K	Price	1.00
IPO	Aug 03, 2023	Option/Short	No / Yes	EPS/Sales Surpr.	10.00% -	Trades		Volume	102,313	Change	-1.96%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)